For Women

Do the examination and choose non-collision gynecological solutions.

Did you know that some medications, in the presence of a genetic mutation, can multiply increase the risk of developing oncological diseases? You can lower this risk by checking your situation through DNA/micro testing.

Studies have shown that women using hormone replacement therapy (HRT) have a higher risk of developing breast cancer compared to women not using hormone therapy. The Million woman study showed that the use of HRT increases the risk of developing breast cancer – the risk is 1.7 times higher than in the general population. The most common cancer, which has been steadily increasing among women in Poland for 50 years, is breast cancer, which accounts for 23.8% of all cancers in this group.

According to current knowledge, oral contraception minimally increases the risk of:

In healthy carriers of mutations in the BRCA1/2 gene, genetic counseling centers advise against using HRT due to the cumulative risk of developing breast cancer and cardiovascular diseases related to a strong hereditary predisposition to the development of this cancer and age.

The presence of a BRCA1 mutation in women may increase the risk of breast cancer by up to 50-80%. and ovarian cancer by up to 44%. In women with a mutation in the BRCA2 gene, the probability of developing the disease is: 56% (breast cancer) and 27% (ovarian cancer), respectively. Mutations in the BRCA1/2 genes are also strong association with an increased predisposition to the development of fallopian tube, pancreas, stomach and colon cancer